
浏览全部资源
扫码关注微信
河南省中医院,郑州 450002
左瑞庭,硕士,主治医师,从事中医风湿骨病研究,E-mail:zuoruiting123@sohu.com
谷慧敏,硕士,副主任医师,从事中医风湿骨病研究,Tel:0371-69915492,E-mail:guhuimin6666@163.com
网络出版日期:2020-06-10,
纸质出版日期:2020-08-20
移动端阅览
左瑞庭,孟庆良,马俊福等.桂苓甘露饮加减联合秋水仙碱治疗湿热蕴结型痛风性关节炎的临床观察[J].中国实验方剂学杂志,2020,26(16):113-118.
ZUO Rui-ting,MENG Qing-liang,MA Jun-fu,et al.Efficacy of Modified Guiling Ganluyin Combined with Colchicine in Treatment of Gouty Arthritis with Damp-heat Accumulation[J].Chinese Journal of Experimental Traditional Medical Formulae,2020,26(16):113-118.
左瑞庭,孟庆良,马俊福等.桂苓甘露饮加减联合秋水仙碱治疗湿热蕴结型痛风性关节炎的临床观察[J].中国实验方剂学杂志,2020,26(16):113-118. DOI: 10.13422/j.cnki.syfjx.20201629.
ZUO Rui-ting,MENG Qing-liang,MA Jun-fu,et al.Efficacy of Modified Guiling Ganluyin Combined with Colchicine in Treatment of Gouty Arthritis with Damp-heat Accumulation[J].Chinese Journal of Experimental Traditional Medical Formulae,2020,26(16):113-118. DOI: 10.13422/j.cnki.syfjx.20201629.
目的
2
观察桂苓甘露饮加减联合秋水仙碱治疗湿热蕴结型痛风性关节炎(GA)的临床疗效,并探讨其机制。
方法
2
将210例GA患者随机分为中药组(70例),西药组(70例)和联合组(70例),分别口服桂苓甘露饮加减、秋水仙碱、桂苓甘露饮加减联合秋水仙碱,疗程均为30 d。观察治疗前后3组临床症状[关节疼痛视觉模拟评分(VAS)、自我感觉的总体评价(PGA)、疼痛数字评价量表(NRS)],血清和关节液中炎性因子[肿瘤坏死因子-
α
(TNF-
α
),白细胞介素-1
β
(IL-1
β
),尿酸(UA)],血液流变学指标[全血高切黏度(HCV),全血低切黏度(LCV),血液还原黏度(RV)]
;比较3组总有效率和不良反应发生率。
结果
2
研究期间脱落6例。联合组总有效率97.1%(67/69),高于中药组的80.8%(55/68)(
χ
2
=8.153,
P
<
0.05)和西药组的79.1%(53/67)(
χ
2
=8.735,
P
<
0.05)。与中药组和西药组治疗后比较,联合组临床症状VAS和NRS评分明显降低(
P
<
0.05),PGA评分明显升高(
P
<
0.05);联合组血清和关节液中炎性因子指标TNF-
α
,IL-1
β
和UA 含量明显降低(
P
<
0.05);联合组血液流变学指标HCV,LCV,RV明显降低(
P
<
0.05)。与联合组治疗期间不良反应发生率比较,西药组的不良反应升高(
χ
2
=5.538,
P
<
0.05),中药组降低(
χ
2
=6.273,
P
<
0.05)。
结论
2
桂苓甘露饮加减联合秋水仙碱具有增效减毒的作用,可明显改善湿热蕴结型GA患者的临床症状,不良反应发生率低。
Objective
2
To explore the clinical efficacy of modified Guiling Ganluyin combined with colchicine in treatment of gouty arthritis(GA) damp-heat accumulation.
Method
2
A total of 210 cases of GA were randomly divided into traditional Chinese medicine(TCM) group(70 cases)
western medicine group (70 cases)
and integrated traditional Chinese and western medicine group(70 cases) according to the digital table method. The patients in TCM group were treated with modified Guiling Ganluyin
the patients in western medicine group were treated with colchicine
and the patients in integrated traditional Chinese and western medicine group received modified Guiling Ganluyin + colchicine
with a treatment course of 30 d in all groups. The clinical symptoms before and after the treatment [joint pain visual analogue scale(VAS)
patient global appraise(PGA)
number rating scale for pain(NRS)]
inflammatory cytokines in serum and joint fluid [tumor necrosis factor-alpha(TNF-
α
)
interleukin-1
β(
IL-1
β
)
uric acid(UA)]
hemorheology index [whole blood high cut viscosity(HCV)
whole blood low cut viscosity(LCV)
whole blood reductive viscosity(RV)]
in 3 groups were observed. The total effective rate and the adverse reactions were compared.
Result
2
Six cases fell off during the study period. The total effective rate in integrated traditional Chinese and western medicine group was 97.1%(67/69)
which higher than 80.8%(55/68) in TCM group (
χ
2
=8.153
P
<
0.05) and 79.1%(53/67) in western medicine group (
χ
2
=8.735
P
<
0.05). Compared with TCM group and western medicine group
the clinical symptoms VAS and NRS scores in integrated traditional Chinese and western medicine group were significantly lower(
P
<
0.05)
while the PGA scores were significantly higher(
P
<
0.05). TNF-
α
IL-1
β
and UA in serum and articular fluid in integrated traditional Chinese and western medicine group were significantly decreased(
P
<
0.05). HCV
LCV and RV were significantly decreased in integrated traditional Chinese and western medicine group(
P
<
0.05). Compared with the traditional Chinese and western medicine group
the incidence of adverse reactions was higher in the western medicine group (
χ
2
=5.538
P
<
0.05) and lower in the Chinese medicine group (
χ
2
=6.273,
P
<
0.05).
Conclusion
2
Modified Guiling Ganluyin combined with colchicine has the effects in enhancing effect and reducing toxicity
and could improve the clinical symptoms of GA patients with damp-heat accumulation
with a low incidence of adverse reactions.
刘宜峰 , 曹磊 , 杨华 , 等 . 薏苡仁汤加减内外合治对急性痛风性关节炎湿热痹阻证炎症因子的影响 [J]. 中国实验方剂学杂志 , 2020 , 26 ( 9 ): 75 - 80 .
YANG T H , YAN D X , HUANG X Y , et al . Termipaniculatones A-F,chalcone-flavonone heterodimers from Terminthia paniculata ,and their protective effects on hyperuricemia and acute gouty arthritis [J]. Phytochemistry , 2019 , 164 ( 8 ): 228 - 235 .
OGDIE A , TAYLOR W J , WEATHERALL M , et al . Imaging modalities for the classification of gout:systematic literature review and Meta-a-nalysis [J]. Ann Rheum Dis , 2015 , 74 ( 10 ): 1868 - 1874 .
ZHANG Q B , ZHU D , WEN Z , et al . High levels of serum uric acid,cystain C and lipids concentration and their clinical significance in primary gouty arthritis patients [J]. Curr Rheumatol Rev , 2019 , 15 ( 2 ): 141 - 145 .
郭玉星 , 熊辉 , 易法银 , 等 . 蠲痹历节清方对改良痛风性关节模型大鼠滑膜的TLR4,NF- κ B,PPAR γ 的影响 [J]. 中国实验方剂学杂志 , 2018 , 24 ( 23 ): 126 - 133 .
周子朋 , 郑福增 , 孟庆良 , 等 . 基于NALP3炎性体信号通路研究栀黄止痛颗粒治疗大鼠痛风性关节炎的作用机制 [J]. 中国实验方剂学杂志 , 2018 , 24 ( 8 ): 140 - 147 .
滕方舟 , 蔡唐彦 , 郭洁梅 , 等 . 痛风宁对急性痛风性关节炎模型大鼠IL-1 β ,TNF- α 及NALP3炎性体的影响 [J]. 中国实验方剂学杂志 , 2018 , 24 ( 17 ): 120 - 125 .
金晓敏 , 张晓熙 , 郭璐 , 等 . 基于 NLRP3 炎性体轴探讨土茯苓总黄酮对痛风性关节炎的作用和机制 [J]. 中国实验方剂学杂志 , 2018 , 24 ( 4 ): 90 - 95 .
李建 , 张洁瑛 , 孙鹏 , 等 . 平胃散合桂枝芍药知母汤加减治疗慢性痛风性关节炎的疗效机制 [J]. 中国实验方剂学杂志 , 2018 , 24 ( 1 ): 180 - 185 .
谷慧敏 , 孟庆良 , 左瑞庭 , 等 . 蚕矢汤加减治疗痛风性关节炎湿热蕴结证临床观察 [J]. 中国实验方剂学杂志 , 2017 , 23 ( 24 ): 180 - 184 .
WALLACE S L , ROBINSON H , MASI A T , et al . Preliminary criteria for the classification of the acute arthritis of primary gou [J]. Arthritis Rheum , 1977 , 20 ( 3 ): 895 - 900 .
国家中医药管理局 . 中华人民共和国中医药行业标准·中医病证诊断疗效标准 [M]. 南京 : 南京大学出版社 , 2010 : 206 .
中华医学会风湿病学分会 . 2016 中国痛风诊疗指南 [J]. 浙江医学 , 2017 , 39 ( 21 ): 1823 - 1824 .
GRAINGER R , TAYLOR W J , DALBETH N , et al . Progress in measurement instruments for acute and chronic gout studies [J]. J Rheumatol , 2009 , 36 ( 10 ): 2346 - 2355 .
SINGH J A , YANG S , STRAND V , et al . Validation of pain and patient global scales in chronic gout:data from two randomised controlled trials [J]. Ann Rheum Dis , 2011 , 70 ( 7 ): 1277 - 1281 .
WALLACE S L , ROBINSON H , MASI A T , et al . Preliminary criteria for the classification of the acute arthritis of primary gout [J]. Arthritis Rheum , 1977 , 20 ( 3 ): 895 - 900 .
梁晖 , 张意侗 , 解纪惠 , 等 . 急性痛风性关节炎的中药治疗进展 [J]. 中国中医急症 , 2019 , 28 ( 3 ): 553 - 556 .
刘婷 , 张霞 , 李飞燕 . 急性痛风性关节炎的中西医治疗进展 [J]. 中国中医急症 , 2019 , 28 ( 2 ): 374 - 376 .
韦秋琴 , 张祖隆 . 秋水仙碱抗炎、抗纤维化及抗肿瘤的研究进展 [J]. 中国现代医学杂志 , 2020 , 30 ( 4 ): 76 - 81 .
周厚明 , 姚真荣 , 项婷 , 等 . 加味四妙散对急性痛风性关节炎大鼠模型疗效的影响 [J]. 中药材 , 2018 , 41 ( 6 ): 1486 - 1488 .
于栋华 , 宋明洋 , 王霄阳 , 等 . 穿山龙提取物抗急性痛风性关节炎的尿液代谢组学分析 [J]. 中国实验方剂学杂志 , 2020 , 26 ( 8 ): 130 - 137 .
MEI J T , ZHOU F , QIAO H , et al . Nerve modulation therapy in gouty arthritis:targeting increased sFRP2 expression in dorsal root ganglion regulates macrophage polarization and alleviates endothelial damage [J]. Theranostics , 2019 , 9 ( 13 ): 3707 - 3722 .
杨俐 , 孟祥霄 , 李洪运 , 等 . 川黄柏和关黄柏全球产地生态适宜性分析 [J]. 中国实验方剂学杂志 , 2019 , 25 ( 4 ): 167 - 174 .
王琛 , 吴智兵 , 林兴栋 , 等 . 大黄素对慢性压迫性损伤大鼠脊髓细胞因子的影响 [J]. 中成药 , 2019 , 41 ( 7 ): 1697 - 1701 .
乔建军 . 并祛丹对急性痛风性关节炎大鼠血清UA、IL-1 β 及TNF- α 的影响 [J]. 西部中医药 , 2019 , 32 ( 7 ): 20 - 23 .
LOPEZ T B , NAJERA M M , MADERA S R , et al . Are related GABA and acetylcholine with the synthesis of IL-1 β ,TNF- α and TGF- β in the immune system organs of the Nile tilapia [J]. Fish Shellfish Immunolo , 2019 , 91 ( 8 ): 393 - 394 .
SHADIOW J , TARUMI T S , DHINDSA M , et al . A comparison of whole blood viscosity and hematocrit levels between yoga practitioners and sedentary adults [J]. Int J Exerc Sci , 2019 , 12 ( 2 ): 425 - 432 .
0
浏览量
17
下载量
1
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621